Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations

By M. Fisher, G. Feuerstein, D. Howells, P. Hurn, T. Kent, S. Savitz, Eng H. Lo. Stroke, 2009

1,292 citations recorded by the source corpus.

The initial Stroke Therapy Academic Industry Roundtable (STAIR) recommendations published in 1999 were intended to improve the quality of preclinical studies of purported acute stroke therapies. Although recognized as reasonable, they have not been closely followed nor rigorously validated. Substantial advances have occurred regarding the appropriate quality and breadth of preclinical testing for candidate acute stroke therapies for better clinical translation. The updated STAIR preclinical recommendations reinforce the previous suggestions that reproducibly defining dose response and time windows with both histological and functional outcomes in multiple animal species with appropriate physiological monitoring is appropriate. The updated STAIR recommendations include: the fundamentals of good scientific inquiry should be followed by eliminating randomization and assessment bias, a priori defining inclusion/exclusion criteria, performing appropriate power and sample size calculations, and disclosing potential conflicts of interest. After initial evaluations in young, healthy male animals, further studies should be performed in females, aged animals, and animals with comorbid conditions such as hypertension, diabetes, and hypercholesterolemia. Another consideration is the use of clinically relevant biomarkers in animal studies. Although the recommendations cannot be validated until effective therapies based on them emerge from clinical trials, it is hoped that adherence to them might enhance the chances for success.

Subfields: Epidemiology, Neurology, Small Animals

View Paper: https://www.semanticscholar.org/paper/50349c7b5372c96d96c90e0425f48e3dc0be01fc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. L. Du
2. Y. Niu
3. F. Sun
4. Chao Zhang
5. Sheng Li
6. Yonggang Zhang
7. J. Kwong
8. Xiantao Zeng

Citations in the corpus

• Animal models of ischemic stroke and their application in clinical research (2015, background): “replicable in a further stroke model (ie, permanent and then transient occlusion model).(10) Table 1 Advantages and disadvantages of the most used rodent stroke models”
• Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. (2012, neutral): “…TBI have been made (Loane and Faden, 2010), and they build on the STAIR criteria for development of neuroprotective treatments for stroke/ischemia (Fisher et al., 2009; STAIR, 1999), and are in line with NIH guidelines for effective therapies for TBI (Margulies and Hicks, 2009; Saatman et al.,…”
• The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta‐analysis, and clinical practice guideline: a systematic review (2015, methodology): “Table S6 shows the updated Stroke Therapy Academic Industry Roundtable (STAIR) tool (50)—Recommendations for Ensuring Good Scientific Inquiry (51), the revised STAIR tool—”